Axa’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,359
| Closed | -$229K | – | 1076 |
|
|
2024
Q1 | $229K | Sell |
3,359
-2,399
| -42% | -$164K | ﹤0.01% | 1013 |
|
|
2023
Q4 | $360K | Buy |
+5,758
| New | +$360K | ﹤0.01% | 973 |
|
|
2022
Q4 | – | Sell |
-112,559
| Closed | -$7.36M | – | 1154 |
|
|
2022
Q3 | $7.36M | Buy |
112,559
+9,639
| +9% | +$630K | 0.03% | 496 |
|
|
2022
Q2 | $6.25M | Buy |
102,920
+8,910
| +9% | +$541K | 0.02% | 528 |
|
|
2022
Q1 | $5.9M | Buy |
94,010
+21,101
| +29% | +$1.32M | 0.02% | 604 |
|
|
2021
Q4 | $5.53M | Buy |
72,909
+872
| +1% | +$66.1K | 0.01% | 642 |
|
|
2021
Q3 | $8.06M | Buy |
72,037
+11,861
| +20% | +$1.33M | 0.02% | 553 |
|
|
2021
Q2 | $9.74M | Buy |
60,176
+53,176
| +760% | +$8.61M | 0.03% | 517 |
|
|
2021
Q1 | $853K | Buy |
+7,000
| New | +$853K | ﹤0.01% | 999 |
|
|
2018
Q4 | – | Sell |
-5,100
| Closed | -$226K | – | 1312 |
|
|
2018
Q3 | $226K | Hold |
5,100
| – | – | ﹤0.01% | 1278 |
|
|
2018
Q2 | $300K | Buy |
+5,100
| New | +$300K | ﹤0.01% | 1230 |
|